Researchers at the University’s Boyce Thompson Institute have recently uncovered that aspirin might not be working the way most doctors think it does. Prof. Daniel Klessig, plant science at BTI, has been studying aspirin and its metabolite salicylic acid (S.A.) for the last 25 years. His most recent findings, published in Molecular Medicine earlier this year, offer an alternate explanation for how aspirin works, focusing on the interaction between S.A. and the body. These findings help account for some of aspirin’s unexplainable benefits, like how it reduces the risk of a variety of cancers. Aspirin is one of the world’s most utilized drugs, with over 80 million tablets being consumed daily by Americans alone.